Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 4Rectal Neoplasms 3Ovarian Neoplasms 3Kidney Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Uveal Melanoma 2Sarcoma 2Melanoma 2Lymphoma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Choroid Plexus Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms, Male 2Astrocytoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

Temozolomide 6O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Filgrastim 3Vorinostat 2Specimen Handling 2Radiotherapy 2Oxaliplatin 2Irinotecan 2Erlotinib Hydrochloride 2Carboplatin 2veliparib 1sargramostim 1romidepsin 1phenylacetic acid 1pembrolizumab 1palbociclib 1olaparib 1ixabepilone 1ispinesib 1erdafitinib 1cediranib 1becatecarin 1alvocidib 1X-Rays 1Verteporfin 1Thiotepa 1Tamoxifen 1Sunitinib 1RMP 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Familial ependymoma × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT00360854 2013-09-20

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

National Cancer Institute (NCI)

Phase 1 Unknown
48 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡